Enveric Biosciences, Inc. (ENVB) ownership: Top institutional holder: GEODE CAPITAL MANAGEMENT, LLC ($62368.00). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 32149.00 | $62368.00 | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 37012.00 | $44785.00 | 2025-06-30 |
| AdvisorShares Investments LLC | 16974.00 | $32930.00 | 2026-03-31 |
| MORGAN STANLEY | 13020.00 | $15754.00 | 2025-06-30 |
| CITADEL ADVISORS LLC | 22674.00 | $14498.00 | 2025-09-30 |
| CITIGROUP INC | 2276.00 | $8262.00 | 2025-12-31 |
| UBS Group AG | 3612.00 | $7008.00 | 2026-03-31 |
| VANGUARD GROUP INC | 18198.00 | $6515.00 | 2024-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 |
Back to ENVB overview · ENVB earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.